About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Adra2atm1Bkk
targeted mutation 1, Brian K Kobilka
MGI:2179108
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Adra2atm1Bkk/Adra2atm1Bkk involves: 129S1/Sv * 129X1/SvJ MGI:3784867
hm2
Adra2atm1Bkk/Adra2atm1Bkk involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:2179110
hm3
Adra2atm1Bkk/Adra2atm1Bkk involves: 129S1/Sv * 129X1/SvJ * C57BL/6J MGI:5508327
cx4
Adra2atm1Bkk/Adra2atm1Bkk
Adra2btm1Gsb/Adra2btm1Gsb
Adra2ctm1Gsb/Adra2ctm1Gsb
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2J MGI:3039647
cx5
Adra2atm1Bkk/Adra2atm1Bkk
Adra2ctm1Gsb/Adra2ctm1Gsb
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2J MGI:3039688


Genotype
MGI:3784867
hm1
Allelic
Composition
Adra2atm1Bkk/Adra2atm1Bkk
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Adra2atm1Bkk mutation (1 available); any Adra2a mutation (5 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• unlike in wild-type mice, hyperglycemia cannot be induced by treatment with 3-iodothyronamine and/or 6-OH dopamine (J:130781)
• unlike in wild-type mice, hyperglycemia cannot be induced by treatment with 3-iodothyronamine and/or 6-OH dopamine (J:130781)
• following treatment with 3-iodothyronamine (J:130781)
• following treatment with 3-iodothyronamine (J:130781)




Genotype
MGI:2179110
hm2
Allelic
Composition
Adra2atm1Bkk/Adra2atm1Bkk
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Adra2atm1Bkk mutation (1 available); any Adra2a mutation (5 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• resting heart rate more than 180 beats/min greater than normal (J:76317)
• resting heart rate more than 180 beats/min greater than normal (J:76317)
• unlike wild-type controls, administration of the hypotensive agonist, dexmedetomidine, did not reduce blood pressure (J:76317)
• unlike wild-type controls, administration of the hypotensive agonist, dexmedetomidine, did not reduce blood pressure (J:76317)

nervous system
• increased release at high frequency electrical stimulation (J:58591)
• decreased release at low frequency electrical stimulation (J:58591)
• increased release at high frequency electrical stimulation (J:58591)
• decreased release at low frequency electrical stimulation (J:58591)




Genotype
MGI:5508327
hm3
Allelic
Composition
Adra2atm1Bkk/Adra2atm1Bkk
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Adra2atm1Bkk mutation (1 available); any Adra2a mutation (5 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• mice treated with epinephrine fail to reduce burst frequency of induced epileptiform activity unlike in control mice (J:197965)
• mice treated with epinephrine fail to reduce burst frequency of induced epileptiform activity unlike in control mice (J:197965)

nervous system
• mice treated with epinephrine fail to reduce burst frequency of induced epileptiform activity unlike in control mice (J:197965)
• mice treated with epinephrine fail to reduce burst frequency of induced epileptiform activity unlike in control mice (J:197965)




Genotype
MGI:3039647
cx4
Allelic
Composition
Adra2atm1Bkk/Adra2atm1Bkk
Adra2btm1Gsb/Adra2btm1Gsb
Adra2ctm1Gsb/Adra2ctm1Gsb
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Adra2atm1Bkk mutation (1 available); any Adra2a mutation (5 available)
Adra2btm1Gsb mutation (1 available); any Adra2b mutation (4 available)
Adra2ctm1Gsb mutation (2 available); any Adra2c mutation (6 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• triple homozygous mutant embryos died between E9.5-E11.5 (J:77486)
• triple homozygous mutant embryos died between E9.5-E11.5 (J:77486)

cardiovascular system
N
• at E9.5, triple mutant embryos had a normal heart rate and a normal cardiac structure (J:77486)
• at E9.5, triple mutant embryos had a normal heart rate and a normal cardiac structure (J:77486)
• at E10.5, only moribund triple mutant embryos displayed bradycardia (J:77486)
• also, triple mutant embryos had normal concentrations of L-dopa and noradrenaline but exhibited a reduction in basal phosphorylation of mitogen activated protein kinase-1 and -3 (J:77486)
• at E10.5, only moribund triple mutant embryos displayed bradycardia (J:77486)
• also, triple mutant embryos had normal concentrations of L-dopa and noradrenaline but exhibited a reduction in basal phosphorylation of mitogen activated protein kinase-1 and -3 (J:77486)

embryogenesis
• triple mutant mice displayed a significantly reduced density of fetal blood vessels in the placental vascular labyrinth, which leads to embryonic lethality as a result of limited oxygen and nutrient supply (J:77486)
• triple mutant mice displayed a significantly reduced density of fetal blood vessels in the placental vascular labyrinth, which leads to embryonic lethality as a result of limited oxygen and nutrient supply (J:77486)
• the yolk sac of triple homozygous mutant embryos was less vascularized and appeared more translucent relative to wild-type (J:77486)
• the endothelial cells in the yolk sac were often detached from the visceral endoderm cell layer (J:77486)
• the yolk sac of triple homozygous mutant embryos was less vascularized and appeared more translucent relative to wild-type (J:77486)
• the endothelial cells in the yolk sac were often detached from the visceral endoderm cell layer (J:77486)




Genotype
MGI:3039688
cx5
Allelic
Composition
Adra2atm1Bkk/Adra2atm1Bkk
Adra2ctm1Gsb/Adra2ctm1Gsb
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Adra2atm1Bkk mutation (1 available); any Adra2a mutation (5 available)
Adra2ctm1Gsb mutation (2 available); any Adra2c mutation (6 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• double homozygous mutant mice displayed increased plasma noradrenaline concentrations and developed cardiac hypertrophy with reduced left ventricular contractility by 4 months of age (J:58591)
• double homozygous mutant mice displayed increased plasma noradrenaline concentrations and developed cardiac hypertrophy with reduced left ventricular contractility by 4 months of age (J:58591)

nervous system
• the inhibitory effect of brimonidine on norepinephrine release was completely abolished in double homozygous mutant mice (J:58591)
• additional experiments in double homozygous mutant mice demonstrated that ADRA2A inhibits transmitter release at high stimulation frequencies, whereas ADRA2C regulates release at lower levels; both subtypes are, however, required for normal presynaptic control of neurotransmitter release from sympathetic nerves in the heart and from central noradrenergic neurons (J:58591)
• the inhibitory effect of brimonidine on norepinephrine release was completely abolished in double homozygous mutant mice (J:58591)
• additional experiments in double homozygous mutant mice demonstrated that ADRA2A inhibits transmitter release at high stimulation frequencies, whereas ADRA2C regulates release at lower levels; both subtypes are, however, required for normal presynaptic control of neurotransmitter release from sympathetic nerves in the heart and from central noradrenergic neurons (J:58591)





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory